Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 80

1.

Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.

Swoboda RK, Somasundaram R, Caputo L, Ochoa EM, Gimotty PA, Marincola FM, Van Belle P, Barth S, Elder D, Guerry D, Czerniecki B, Schuchter L, Vonderheide RH, Herlyn D.

Cancer Res. 2007 Apr 15;67(8):3555-9.

PMID:
17440064
[PubMed - indexed for MEDLINE]
Free Article
2.

A CD4+, HLA-DR7-restricted T-helper lymphocyte clone recognizes an antigen shared by human malignant melanoma and glioma.

Somasundaram R, Swoboda R, Caputo L, Lee A, Jackson N, Marincola FM, Guerry D, Herlyn D.

Int J Cancer. 2003 Apr 10;104(3):362-8.

PMID:
12569560
[PubMed - indexed for MEDLINE]
3.

A novel strategy for the discovery of MHC class II-restricted tumor antigens: identification of a melanotransferrin helper T-cell epitope.

Röhn TA, Reitz A, Paschen A, Nguyen XD, Schadendorf D, Vogt AB, Kropshofer H.

Cancer Res. 2005 Nov 1;65(21):10068-78.

PMID:
16267033
[PubMed - indexed for MEDLINE]
Free Article
4.

Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner.

Kobayashi H, Nagato T, Sato K, Aoki N, Kimura S, Murakami M, Iizuka H, Azumi M, Kakizaki H, Tateno M, Celis E.

Cancer Res. 2007 Jun 1;67(11):5498-504.

PMID:
17545632
[PubMed - indexed for MEDLINE]
Free Article
5.

Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells.

Castelli C, Ciupitu AM, Rini F, Rivoltini L, Mazzocchi A, Kiessling R, Parmiani G.

Cancer Res. 2001 Jan 1;61(1):222-7.

PMID:
11196165
[PubMed - indexed for MEDLINE]
Free Article
6.

Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cells.

Held G, Neumann F, Sturm C, Kaestner L, Dauth N, de Bruijn DR, Renner C, Lipp P, Pfreundschuh M.

Int J Cancer. 2008 Oct 15;123(8):1841-7. doi: 10.1002/ijc.23728.

PMID:
18688854
[PubMed - indexed for MEDLINE]
7.

MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.

Godet Y, Moreau-Aubry A, Guilloux Y, Vignard V, Khammari A, Dreno B, Jotereau F, Labarriere N.

J Exp Med. 2008 Oct 27;205(11):2673-82. doi: 10.1084/jem.20081356. Epub 2008 Oct 20.

PMID:
18936238
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Identification of a promiscuous HLA DR-restricted T-cell epitope derived from the inhibitor of apoptosis protein survivin.

Piesche M, Hildebrandt Y, Zettl F, Chapuy B, Schmitz M, Wulf G, Trümper L, Schroers R.

Hum Immunol. 2007 Jul;68(7):572-6. Epub 2007 Apr 11.

PMID:
17584578
[PubMed - indexed for MEDLINE]
9.

A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes.

Larrieu P, Renaud V, Godet Y, Jotereau F, Fonteneau JF.

Cancer Immunol Immunother. 2008 May;57(5):745-52. Epub 2007 Dec 21.

PMID:
18097665
[PubMed - indexed for MEDLINE]
10.

Revelation of a cryptic major histocompatibility complex class II-restricted tumor epitope in a novel RNA-processing enzyme.

Topalian SL, Gonzales MI, Ward Y, Wang X, Wang RF.

Cancer Res. 2002 Oct 1;62(19):5505-9.

PMID:
12359760
[PubMed - indexed for MEDLINE]
Free Article
11.

Identification of a novel NY-ESO-1 promiscuous helper epitope presented by multiple MHC class II molecules found frequently in the Japanese population.

Ohkuri T, Sato M, Abe H, Tsuji K, Yamagishi Y, Ikeda H, Matsubara N, Kitamura H, Nishimura T.

Cancer Sci. 2007 Jul;98(7):1092-8. Epub 2007 May 4.

PMID:
17488334
[PubMed - indexed for MEDLINE]
12.

Cross-reactive CD4+ T cells against one immunodominant tumor-derived epitope in melanoma patients.

Kudela P, Janjic B, Fourcade J, Castelli F, Andrade P, Kirkwood JM, El-Hefnawy T, Amicosante M, Maillere B, Zarour HM.

J Immunol. 2007 Dec 1;179(11):7932-40.

PMID:
18025241
[PubMed - indexed for MEDLINE]
Free Article
13.

Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3.

Piesche M, Hildebrandt Y, Chapuy B, Wulf GG, Trümper L, Schroers R.

Vaccine. 2009 Jul 23;27(34):4718-23. doi: 10.1016/j.vaccine.2009.05.010. Epub 2009 May 27.

PMID:
19446593
[PubMed - indexed for MEDLINE]
14.

Isolation of the melanoma-associated antigen p23 using antibody phage display.

Li J, Pereira S, Van Belle P, Tsui P, Elder D, Speicher D, Deen K, Linnenbach A, Somasundaram R, Swoboda R, Herlyn D.

J Immunol. 2001 Jan 1;166(1):432-8.

PMID:
11123321
[PubMed - indexed for MEDLINE]
Free Article
15.

alpha v beta3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen.

Godefroy E, Moreau-Aubry A, Diez E, Dreno B, Jotereau F, Guilloux Y.

J Exp Med. 2005 Jul 4;202(1):61-72.

PMID:
15998788
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design.

Ebert LM, Liu YC, Clements CS, Robson NC, Jackson HM, Markby JL, Dimopoulos N, Tan BS, Luescher IF, Davis ID, Rossjohn J, Cebon J, Purcell AW, Chen W.

Cancer Res. 2009 Feb 1;69(3):1046-54. doi: 10.1158/0008-5472.CAN-08-2926. Epub 2009 Jan 27. Erratum in: Cancer Res. 2009 May 15;69(10):4553.

PMID:
19176376
[PubMed - indexed for MEDLINE]
Free Article
17.

A mycoplasma peptide elicits heteroclitic CD4+ T cell responses against tumor antigen MAGE-A6.

Vujanovic L, Mandic M, Olson WC, Kirkwood JM, Storkus WJ.

Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6796-806.

PMID:
18006782
[PubMed - indexed for MEDLINE]
Free Article
18.

Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5.

Sensi M, Pietra G, Molla A, Nicolini G, Vegetti C, Bersani I, Millo E, Weiss E, Moretta L, Mingari MC, Anichini A.

Int Immunol. 2009 Mar;21(3):257-68. doi: 10.1093/intimm/dxn141. Epub 2009 Jan 30.

PMID:
19181932
[PubMed - indexed for MEDLINE]
Free Article
19.

MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.

Bosch JJ, Thompson JA, Srivastava MK, Iheagwara UK, Murray TG, Lotem M, Ksander BR, Ostrand-Rosenberg S.

Cancer Res. 2007 May 1;67(9):4499-506.

PMID:
17483366
[PubMed - indexed for MEDLINE]
Free Article
20.

The TAG family of cancer/testis antigens is widely expressed in a variety of malignancies and gives rise to HLA-A2-restricted epitopes.

Adair SJ, Carr TM, Fink MJ, Slingluff CL Jr, Hogan KT.

J Immunother. 2008 Jan;31(1):7-17.

PMID:
18157007
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk